Resources and Events

Webinar

State of the Data 2025: Irix Prescription Data

The product that launched a category remains central to your plans for innovation, growth, and business continuity.

White Paper

Those applicants you declined? Their mortality matters more than you think

Partner Re makes clever use of Irix® Risk Score to test industry assumptions about decline mortality.

Article

Six planes down: The magnitude of nicotine’s impact on mortality

Is it time to rethink tobacco underwriting guidelines?

Article

Jet-declining severe obesity is costing life insurance carriers business

You can confidently cover millions more Americans without taking on additional risk.

White Paper

RGA paper shows underwriting gains when adding Medical Data to Prescription Data

There are distinct advantages to stacking the datasets.

Webinar

Revealing the insurable market in severe obesity

Data and modeling find nearly half the applicants in this group with better-than-average mortality.

Webinar

New therapeutics and their mortality impacts

Distinguish higher- from lower-mortality outcomes based on treatment use and other indicators.

Video

Digital risk assessment methods are now core actuarial training

Electronic data has modernized life insurance underwriting.

Watch now

Video

Filter high-morbidity applicants and still issue more business with Medical Data

Medicare Supplement carriers explain how they use medical claims data to transform their business.

Watch now

Article

Recent FDA-approved drugs of interest to underwriters

Understand their health implications so you can confidently assess risk.

Webinar

Interoperability regulations and the new era of EHR data access for life insurance

We're leveraging this new data to flow to deliver Irix EHR.

Article

ACA risk adjustment leaders: You’re leaving big money on the table

Get it back with a predictive model that improves HCC coding for new members.

Webinar

Risk Score “cheat sheet”—new feature helps explain the score

We're making this supertool more transparent with the summary feature.

Article

Five scrappy ways your PEO can use AI to shrink the group health sales cycle

In her PEO Insider article, Kaitlyn Fischer shares savvy insights on using AI to better compete.

Article

Your PEO should use a predictive model for group health underwriting

Dan Becker tells PEO Insider readers how to accelerate sales, improve pricing, and boost retention.

Article

Everyone into the (data) pool

Predictive models are hungry for data, but Michael Niemerg tells The Actuary why more isn't always better.

White Paper

Irix® Risk Score stratifies mortality risk with the addition of Credit Data

This dataset improves hit rates, risk stratification, and straight-through processing.

White Paper

RGA actuarially validates Irix® Risk Score 3.0 with Credit Data

The reinsurer saw increased hit rates and improved segmentation of both the lowest and highest deciles.

Webinar

The latest therapeutics: Underwriting recent and relevant FDA approvals

Learn what these breakthrough drugs imply for risk assessment.

White Paper

Post-acute COVID-19 mortality and morbidity effects

We provide a scientific risk analysis for underwriters and medical directors.

Article

Cutting the bluster on AI in group health underwriting

Let's be level-headed amid the hype.

Webinar

Scores that make you go hmm: When predictive models and underwriters don’t see eye to eye

Human art and data science really can come together for better-than-ever risk assessment.

Podcast

Mike Bishop’s big leap from insurtech customer to insurtech creator

This leader is no laggard. Hear his perspectives on "Get Plugged In".

Watch now

White Paper

Consumer data and its applications in health insurance underwriting

This study found that adding consumer data to our Curv® predictive model yielded almost no incremental lift.

Webinar

A new look at tobacco risk: Revelations from Milliman’s research and clinical data findings

Prescription Data and Medical Data find nicotine dependence history and reveal surprising insights into tobacco’s durable mortality impact.

White Paper

Irix® Risk Score with Medical Data: Stratifying mortality risk by combining datasets

Medical Data added to Prescription Data makes this supertool more super.

White Paper

Hannover Re proves Medical Data’s protective value

Medical Data shines a light on serious conditions that are often missed.

White Paper

RGA puts its actuarial stamp of approval on Irix® Risk Score 3.0

Multiple dataset inputs or not, Risk Score 3.0 delivers heightened risk insight.

Webinar

More than the score: New Curv® condition reporting enhancements and privacy best practices

We've built in more case-level insight and benchmarking features for better risk assessment.

Webinar

Spotting serious diagnoses among common neurological conditions

Use interpreted clinical data to distinguish benign conditions from the serious mortality risks.

Webinar

Therapeutics update: Important new drugs and their mortality implications

Get familiar with the FDA's latest approvals and what they mean for underwriting.

Webinar

Homing in on hormones: Using instant clinical data to underwrite endocrine disorders

Diabetes isn't the only hormonal disease. Learn the risk implications of other major endocrine disorders.

Article

Five ways a morbidity predictive model can relieve Medicare Supplement market pressures

Embrace disruption or be disrupted.

Webinar

Using morbidity Risk Score to tame the wild Medicare Supplement market

Select better lives and reduce overhead.

Webinar

Psychiatric and substance use disorders amid the COVID-19 pandemic

Grasp the complex interplay between psychiatric disorders and mortality to better assess risk.

Video

Accelerated underwriting modernizes workflows and puts the middle market within reach

The case for fluidless, digital risk assessment has never been stronger.

Watch now

Webinar

Underwriting with prescription histories across the mental healthcare continuum

Identify and interpret mental health conditions in life insurance underwriting.

Resources

State of the Data 2025: Irix Prescription Data

Those applicants you declined? Their mortality matters more than you think

Six planes down: The magnitude of nicotine’s impact on mortality

Jet-declining severe obesity is costing life insurance carriers business

RGA paper shows underwriting gains when adding Medical Data to Prescription Data

Revealing the insurable market in severe obesity

New therapeutics and their mortality impacts

Digital risk assessment methods are now core actuarial training

Filter high-morbidity applicants and still issue more business with Medical Data

Recent FDA-approved drugs of interest to underwriters

Interoperability regulations and the new era of EHR data access for life insurance

ACA risk adjustment leaders: You’re leaving big money on the table

Risk Score “cheat sheet”—new feature helps explain the score

Five scrappy ways your PEO can use AI to shrink the group health sales cycle

Your PEO should use a predictive model for group health underwriting

Everyone into the (data) pool

Irix® Risk Score stratifies mortality risk with the addition of Credit Data

RGA actuarially validates Irix® Risk Score 3.0 with Credit Data

The latest therapeutics: Underwriting recent and relevant FDA approvals

Post-acute COVID-19 mortality and morbidity effects

Cutting the bluster on AI in group health underwriting

Scores that make you go hmm: When predictive models and underwriters don’t see eye to eye

Mike Bishop’s big leap from insurtech customer to insurtech creator

Consumer data and its applications in health insurance underwriting

A new look at tobacco risk: Revelations from Milliman’s research and clinical data findings

Irix® Risk Score with Medical Data: Stratifying mortality risk by combining datasets

Hannover Re proves Medical Data’s protective value

RGA puts its actuarial stamp of approval on Irix® Risk Score 3.0

More than the score: New Curv® condition reporting enhancements and privacy best practices

Spotting serious diagnoses among common neurological conditions

Therapeutics update: Important new drugs and their mortality implications

Homing in on hormones: Using instant clinical data to underwrite endocrine disorders

Five ways a morbidity predictive model can relieve Medicare Supplement market pressures

Using morbidity Risk Score to tame the wild Medicare Supplement market

Psychiatric and substance use disorders amid the COVID-19 pandemic

Accelerated underwriting modernizes workflows and puts the middle market within reach

Underwriting with prescription histories across the mental healthcare continuum

Your choices regarding cookies on this site

Required Cookies

Analytics & Performance